# FDA 483 - Utah Valley Hospital - December 11, 2025

Source: https://www.keypedia.com/records/483/utah-valley-hospital/eca6e23f-58a9-404b-951a-556d8241aa05

> FDA 483 for Utah Valley Hospital on December 11, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Utah Valley Hospital
- Inspection Date: 2025-12-11
- Product Type: biologics
- Office Name: Denver District Office
- Summary: The FDA inspected Utah Valley Hospital in Provo, UT, focusing on its Hospital Transfusion Service. The inspection revealed a failure to maintain adequate storage and distribution records for blood products, specifically concerning emergency releases and returns that lacked proper physician signatures as required by the hospital's own Standard Operating Procedure. This indicates a significant lapse in adherence to established procedures for critical blood product management.

## Related Documents

- [483 - 2023-10-06](https://www.keypedia.com/records/483/utah-valley-hospital/a919cfc7-e544-4dcc-996b-827eb08b984a)
- [483 - 2025-12-11](https://www.keypedia.com/records/483/utah-valley-hospital/72e3a71d-836d-4be6-bc00-a24d87cd12c1)

## Related Officers

- [Conor J. Mccarron](https://www.keypedia.com/people/conor-j-mccarron/280401e4-b080-4ba8-ab35-d3b16e91c2b1)

Company: https://www.keypedia.com/companies/utah-valley-hospital/3b2e49e7-08cf-47ee-b005-3500b22f175f

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face